{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:48:21Z","timestamp":1792356501207,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1038\/sj.bmt.1703606","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T18:27:21Z","timestamp":1031077641000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant"],"prefix":"10.1038","volume":"30","author":[{"given":"R","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MD","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"D\u00edez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Urbano-Isp\u00edzua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Odriozola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,22]]},"reference":[{"key":"BF1703606_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/sj.bmt.1702995","volume":"27","author":"A Gratwohl","year":"2001","unstructured":"Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A for the European Group for Blood and Marrow Transplantation (EBMT). Hematopoietic stem cell transplantation in Europe 1999 Bone Marrow Transplant 2001 27: 899 916","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR2","first-page":"646","volume":"86","author":"C Di Grazia","year":"2001","unstructured":"Di Grazia C, Raiola AM, Van Lint MT et al. Conventional hematopoietic stem cell transplantation from identical or alternative donors are feasible in recipients relapsing after an autograft Haematologica 2001 86: 646 651","journal-title":"Haematologica"},{"key":"BF1703606_CR3","first-page":"197a","volume":"96","author":"PA Rowlings","year":"2000","unstructured":"Rowlings PA, Greenstein V, Nivison-Smith I et al. Second allogeneic transplant for leukaemia after a failed first autologous transplant Blood 2000 96: 197a (Abstr.)","journal-title":"Blood"},{"key":"BF1703606_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/sj.bmt.1701634","volume":"23","author":"S Kulkarni","year":"1999","unstructured":"Kulkarni S, Powles RL, Treleaven JG et al. Impact of previous high-dose therapy on outcome after allografting for multiple myeloma Bone Marrow Transplant 1999 23: 675 680","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bmt.1702409","volume":"25","author":"O Ringd\u00e9n","year":"2000","unstructured":"Ringd\u00e9n O, Labopin M, Gorin NC et al. The dismal outcome in patients with acute leukemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed Bone Marrow Transplant 2000 25: 1053 1058","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1083-8791(00)70009-7","volume":"6","author":"JP Radich","year":"2000","unstructured":"Radich JP, Gooley T, Sanders JE et al. Second allogeneic transplantation after failure of first autologous transplantation Biol Blood Marrow Transplant 2000 6: 272 279","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703606_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","volume":"20","author":"T Tsai","year":"1997","unstructured":"Tsai T, Goodman S, Saez R et al. Allogeneic bone marrow transplantation in patients who relapse after an autologous transplantation Bone Marrow Transplant 1997 20: 859 863","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 2001 97: 631 637","journal-title":"Blood"},{"key":"BF1703606_CR9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763","journal-title":"Blood"},{"key":"BF1703606_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","volume":"25","author":"AM Carella","year":"2000","unstructured":"Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans Bone Marrow Transplant 2000 25: 345 350","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR11","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 2001 97: 3390 3400","journal-title":"Blood"},{"key":"BF1703606_CR12","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"PD Kottaridis","year":"2000","unstructured":"Kottaridis PD, Milligan DW, Chopra R et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Blood 2000 96: 2419 2425","journal-title":"Blood"},{"key":"BF1703606_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2141.2001.03153.x","volume":"115","author":"R Martino","year":"2001","unstructured":"Martino R, Caballero MD, Canals C et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicenter study Br J Haematol 2001 115: 653 659","journal-title":"Br J Haematol"},{"key":"BF1703606_CR14","first-page":"103","volume":"23","author":"J De la Serna","year":"2001","unstructured":"De la Serna J, Hern\u00e1ndez-Maraver MD, D\u00edez JL et al. Allogeneic hematopoietic progenitor cell transplantation after non-myeloablative conditioning: results of a multicenter study (Spanish) Methods Find Exp Clin Pharmacol 2001 23: 103 108","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"BF1703606_CR15","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825 830","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimations Stat Med 1999 18: 695 706","journal-title":"Stat Med"},{"key":"BF1703606_CR17","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.bmt.1702722","volume":"26","author":"P Dreger","year":"2000","unstructured":"Dreger P, Glass B, Seyfarth B et al. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT Bone Marrow Transplant 2000 26: 1361 1363","journal-title":"Bone Marrow Transplant"},{"key":"BF1703606_CR18","first-page":"412a","volume":"96","author":"BR Dey","year":"2000","unstructured":"Dey BR, McAfee S, Sackstein R et al. Successful second allogeneic marrow transplantation following non-myeloablative conditioning for patients with relapsed\/refractory lymphoma after failure of autologous transplant Blood 2000 96: 412a (Abstr.)","journal-title":"Blood"},{"key":"BF1703606_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0301-472X(00)00511-7","volume":"28","author":"A Nagler","year":"2000","unstructured":"Nagler A, Or R, Naparstek E et al. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation Exp Hematol 2000 28: 1096 1104","journal-title":"Exp Hematol"},{"key":"BF1703606_CR20","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1182\/blood.V97.9.2574","volume":"97","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Morris C et al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions Blood 2001 97: 2574 2579","journal-title":"Blood"},{"key":"BF1703606_CR21","doi-asserted-by":"crossref","first-page":"553a","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"PD Kottaridis","year":"2000","unstructured":"Kottaridis PD, Milligan DW, Mahendra P et al. Non-myeloablative conditioning limits transplant-related mortality in patients who have previously failed high-dose treatment Blood 2000 96: 553a (Abstr.)","journal-title":"Blood"},{"key":"BF1703606_CR22","first-page":"304","volume":"85","author":"AM Carella","year":"2000","unstructured":"Carella AM, Giralt S, Slavin S . Nonmyeloablative therapy with allogeneic hematopoietic stem cell transplantation as treatment of hematological neoplasia Haematologica 2000 85: 304 313","journal-title":"Haematologica"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703606","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:20:26Z","timestamp":1648077626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["BF1703606"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703606","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]},"assertion":[{"value":"30 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}